Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management

Ravi A. Thakker, Leonardo Salazar, Deaa Abu Jazar, Pooja Bhakta, Bryan Baker, Chandani Patel, Ayman Elbadawi, Mayank Agarwal, Aiham Albaeni, Mohammed Saleh, Jonathan Esclovan, Danielle El Haddad, Hashim Alwash, Ankur Kalra, Sachin S. Goel, Robert Jay Widmer, Khaled Chatila, Wissam Khalife, Afaq Motiwala, Jennifer McCrackenHani Jneid, Syed Gilani

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Aspirin is one of the most widely used medications across the global healthcare system and is the foundation in treating ischemic heart disease, as well as secondary prevention for ischemic and valvular heart disease. Challenges arise in treating patients with cardiovascular disease who have concomitant aspirin intolerance. Through an extensive review of the literature, we provide a comprehensive background on the pharmacology of aspirin, the mechanisms behind aspirin intolerance, the importance of aspirin in cardiovascular disease, and the management of aspirin intolerance in both acute coronary syndrome and stable coronary artery disease. Our review includes a multidisciplinary approach from the internist, allergist/immunologist, and cardiologist when evaluating this important patient population.

Original languageEnglish (US)
Pages (from-to)175-183
Number of pages9
JournalCardiology and Therapy
Issue number2
StatePublished - Jun 2022


  • Acute coronary syndrome
  • Aspirin intolerance
  • Coronary artery disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management'. Together they form a unique fingerprint.

Cite this